Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-[5-(1H-indol-3-yl)-3-trifluoromethyl-4,5-dihydropyrazol-1-yl]-benzenesulfonamide | 0.01 mM inhibits LOX-5 by 41% | Homo sapiens | |
4-[5-(1H-indol-3-yl)-3-trifluoromethyl-4,5-dihydropyrazol-1-yl]-benzenesulfonamide | 0.01 mM inhibits LOX-15 by 31% | Oryctolagus cuniculus | |
4-[5-(6-chloro-1H-indol-3-yl)-3-trifluoromethyl-4,5-dihydropyrazol-1-yl]-benzenesulfonamide | 0.01 mM inhibits LOX-5 by 51% | Homo sapiens | |
4-[5-(6-chloro-1H-indol-3-yl)-3-trifluoromethyl-4,5-dihydropyrazol-1-yl]-benzenesulfonamide | 0.01 mM inhibits LOX-15 by 36% | Oryctolagus cuniculus | |
4-[5-(7-chloro-1H-indol-3-yl)-3-trifluoromethyl-4,5-dihydropyrazol-1-yl]-benzenesulfonamide | 0.01 mM inhibits LOX-5 by 94% | Homo sapiens | |
4-[5-(7-chloro-1H-indol-3-yl)-3-trifluoromethyl-4,5-dihydropyrazol-1-yl]-benzenesulfonamide | 0.01 mM inhibits LOX-15 by 36% | Oryctolagus cuniculus | |
celecoxib | 0.01 mM inhibits LOX-5 by 89% | Homo sapiens | |
celecoxib | 0.01 mM inhibits LOX-15 by 22% | Oryctolagus cuniculus | |
rofecoxib | 0.01 mM inhibits LOX-5 by 11% | Homo sapiens | |
rofecoxib | 0.01 mM inhibits LOX-15 by 6% | Oryctolagus cuniculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Oryctolagus cuniculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
additional information | PBML cells | Homo sapiens | - |
reticulocyte | LOX-15 | Oryctolagus cuniculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
arachidonate + O2 | - |
Homo sapiens | (6E,8Z,11Z,14Z)-(5S)-5-hydroperoxyicosa-6,8,11,14-tetraenoate | - |
? | |
arachidonate + O2 | - |
Oryctolagus cuniculus | (6E,8Z,11Z,14Z)-(5S)-5-hydroperoxyicosa-6,8,11,14-tetraenoate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
lipoxygenase 15 | - |
Oryctolagus cuniculus |
lipoxygenase 5 | - |
Homo sapiens |
LOX-15 | - |
Oryctolagus cuniculus |
LOX-5 | - |
Homo sapiens |